Bill > HR6875

This bill, the Right Drug Dose Now Act, seeks to update the National Action Plan for Adverse Drug Event Prevention to provide educational information on adverse drug events and pharmacogenomic testing, and to improve electronic health records (EHRs) for pharmacogenomic information. It requires the Secretary of Health and Human Services to submit a report on the implementation of the National Action Plan, convene the Federal Interagency Steering Committee to update the plan, and consider advances in scientific understanding and technology related to drug-gene-drug interactions, clinical outcomes, and the decreasing cost of genetic testing. The bill also establishes public and health care professional education campaigns on adverse drug events and pharmacogenomic testing, and requires the Secretary to adopt certification criteria for health information technology to indicate when pharmacogenomic testing is appropriate and to report adverse drug events associated with pharmacogenetic interactions. Additionally, the bill increases authorization for pharmacogenomics implementation research.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/117th-congress/house-bill/6875/all-info